Eli Lilly and Company
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.01 | 10.35 | 9.70 | 12.50 | 12.64 | 14.98 | 14.13 | 17.29 | 19.58 | 21.48 | 22.10 | 25.71 | 89.14 | |
| 1.96 | 1.98 | 1.85 | 2.40 | 2.40 | 2.66 | 2.47 | 2.72 | 3.35 | 3.75 | 3.99 | 3.66 | 14.80 | |
| 8.05 | 8.37 | 7.85 | 10.10 | 10.24 | 12.32 | 11.66 | 14.57 | 16.24 | 17.73 | 18.11 | 22.05 | 74.34 | |
| 2.54 | 2.83 | 2.79 | 3.00 | 3.02 | 3.35 | 3.04 | 3.71 | 3.86 | 4.23 | 3.92 | 4.27 | 16.33 | |
| 1.78 | 2.00 | 2.03 | 2.22 | 2.19 | 2.56 | 2.62 | 2.94 | 3.05 | 3.72 | 3.27 | 3.84 | 13.93 | |
| 4.32 | 4.84 | 4.82 | 5.21 | 5.21 | 5.90 | 5.66 | 6.65 | 6.91 | 7.72 | 7.19 | 8.11 | 30.02 | |
| 3.73 | 3.53 | 3.03 | 4.89 | 5.03 | 6.42 | 6.01 | 7.92 | 9.33 | 10.01 | 10.91 | 13.94 | 44.32 | |
| 0.13 | 0.15 | 0.20 | 0.20 | 0.21 | 0.25 | 0.27 | 0.28 | 0.20 | 0.14 | 0.37 | 0.39 | 1.10 | |
| 0.45 | 2.78 | 2.81 | 3.89 | 1.76 | 5.58 | 3.84 | 7.53 | 8.05 | 9.21 | 9.88 | 10.35 | 37.59 | |
| 0.51 | 0.35 | 0.32 | 0.61 | 0.68 | 0.70 | 0.77 | 1.24 | 1.84 | 1.81 | 1.62 | 2.41 | 7.70 | |
| -0.06 | 2.42 | 2.48 | 3.28 | 1.07 | 4.88 | 3.06 | 6.29 | 6.21 | 7.39 | 8.26 | 7.94 | 29.89 | |
| 1.01 | 3.36 | 3.45 | 4.55 | 2.48 | 6.36 | 4.62 | 8.34 | 8.77 | 13.52 | 11.48 | 14.54 | 48.46 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.